Delivery Order SPE2DB20D3101-SPE2DB24FRUX6

Award Date 9/14/24
Potential Completion Date 9/16/24
Potential Value $4.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of 620 mcg/2.48 ml vials of the drug teriparatide. The contract is a firm fixed-price delivery order with a ceiling value of $16,819.13 and a period of performance through May 19, 2025. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not set aside. The company also holds a larger $999,999,999.00 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,732.66, is for the delivery of TERIPARATIDE 620 MCG/2.48 ML 2.48ML, a specialty medication. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a $37,640.12 Firm Fixed Price Delivery Order, is for the supply of 4,567,944,238 units of the medication Teriparatide 560mcg/2.24ml Pen 2.24ml. The contract has an ultimate completion date of April 17, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,198,697 units of the drug Teriparatide 600 mcg/2.4 ml pen. The contract has a ceiling value of $4,419.64 and a completion date of October 25, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract was not set aside for any specific business type. AmerisourceBergen holds a significant...
This federal contract award is a delivery order with a firm fixed price valued at $1,843.27. The award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of TERIPARATIDE 620 MCG/2.48 ML 2.48ML. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price, valued at $5,510.61, for the delivery of 4567171361 - TERIPARATIDE 600 MCG/2.4ML PEN 2.4ML, a specialty medication. The contract has an ultimate completion date of February 6, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $5,108.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,568,078,779 units of the medication Teriparatide 560MCG/2.24ML Pen 2.24ML. The contract has an ultimate completion date of April 30, 2025 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corporation, a wholly owned subsidiary of Amerisourcebergen Corporation, to provide 4,563,927,592 units of the pharmaceutical product Teriparatide 600 mcg/2.4ml pen at a ceiling value of $2,299.97. The award, which has an ultimate completion date of March 12, 2024, is part of a larger indefinite delivery contract (IDC) valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,564,464,842 units of Teriparatide 600 mcg/2.4 ml pen, 2.4 ml. The contract is a firm fixed-price delivery order with a ceiling value of $8,225.76 and an ultimate completion date of May 2, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Teriparatide 620 mcg/2.48 ml 2.48 ml. The contract, valued at $6,403.31, is a delivery order with a firm fixed price. The contract has an ultimate completion date of December 4, 2023 and was awarded on December 1, 2022. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which is the...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRUX6
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) is a delivery order (SPE2DB20D3101|SPE2DB24FRUX6) for the pharmaceutical product Teriparatide 620 mcg/2.48 ml, 2.48 ml. The contract has a firm fixed price of $4,273.08 and an ultimate completion date of September 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing this product under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for the DLA to procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 2/27/25, 12:40 PM